Botanical species · safety record

Opuntia streptacantha

The EFSA Compendium of Botanicals holds 1 constituent measurement and 1 adverse-effect record for Opuntia streptacantha. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Opuntia streptacantha Lem.

1Constituent measurements

1Safety records

2Cited sources

11Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 11 licensed products naming Opuntia streptacantha as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Cactus
Fruit
Leaf
Stem(s)
Whole plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Calcium oxalate	Stem / stalk	Drying (dehydration)	—	IR and Raman Spectroscopy	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Seed	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Torres-Castillo, J. A., Mondragon Jacobo, C., Blanco-Labra, A. Characterization of a highly stable trypsin-like proteinase inhibitor from the seeds of Opuntia streptacantha (O. streptacantha Lemaire) . Phytochemistry, 2009, vol. 70, no. 11-12, p. 1374-1381. DOI
Frausto-Reyes, Claudio., Loza-Cornejo, Sofia., Terrazas, Teresa., Miranda-Beltran, Maria de la Luz., Aparicio-Fernandez, Xochiti., Lopez-Macias, Brenda M., Morales-Martinez, Sandra E., Ortiz-Morales, Martin. Raman spectroscopy study of calcium oxalate extracted from cacti stems. Applied Spectroscopy, 2014, p. 1260-1265.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature